NDAORALTABLET
Approved
Jun 1994
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
11
Mechanism of Action
anti-alpha herpes viral agent penciclovir [see Microbiology ( ) ] .
Clinical Trials (5)
Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
Started Mar 2009
53 enrolled
Herpes Labialis
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
Started Oct 2007
18 enrolled
Herpes Simplex
Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
Started Mar 2006
1,179 enrolled
Genital Herpes
Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
Started Jul 2005
76 enrolled
ChickenpoxHerpes Zoster
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
Started Feb 2005
74 enrolled
Herpes Simplex